FGFR1 and mixed neuronal-glial tumor: Among the low grade glial or glioneuronal tumor cohort, all selected cases with BRAF V600E mutation (5/5) or FGFR1 N546K or K656E mutation (5/5) evaluated by HRM-sequencing were also detected with the mdPCR assays.